Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00461149
Status:
COMPLETED
Last Update Posted:
2007-04-17
First Post:
2007-04-13
Brief Title:
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Sponsor:
Federico II University
Organization:
Federico II University
Organization Data
Organization:
Federico II University
Class:
OTHER
Study ID:
NeuroendoUnit-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Federico II University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None